Altundag, K. Et Al. 2007. The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern. AMERICAN JOURNAL OF SURGERY , vol.194, no.2 , 272-273.

Altundag, K., Bulut, N., Sari, E., & Harputluoglu, H., (2007). The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern. AMERICAN JOURNAL OF SURGERY , vol.194, no.2, 272-273.

Altundag, Kadri Et Al. "The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern," AMERICAN JOURNAL OF SURGERY , vol.194, no.2, 272-273, 2007

Altundag, Kadri Et Al. "The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern." AMERICAN JOURNAL OF SURGERY , vol.194, no.2, pp.272-273, 2007

Altundag, K. Et Al. (2007) . "The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern." AMERICAN JOURNAL OF SURGERY , vol.194, no.2, pp.272-273.

@article{article, author={Kadri Altundag Et Al. }, title={The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern}, journal={AMERICAN JOURNAL OF SURGERY}, year=2007, pages={272-273} }